IRulya Therapeutics
$33.55
0
+$0.60+1.82%Monday 21:00
+$0.00+0%00:30After hours
Statistics
Day High
33.72
Day Low
31.02
52W High
910
52W Low
15.1
Volume
96,468
Avg. Volume
43,398
Mkt Cap
34.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 18Expected
Q2 2026
Next
-28.02
-19.14
-10.26
-1.39
Expected EPS
-1.385
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-83.98MNet Income
Analyst Ratings
$62.50Average Price Target
The highest estimate is 82.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 83%
Hold 17%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IRLA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
Editas Medicine
EDIT
Mkt Cap410.06M
Intellia Therapeutics
NTLA
Mkt Cap1.75B
Voyager Therapeutics
VYGR
Mkt Cap105.98M
Protagonist Therapeutics
PTGX
Mkt Cap9.37B
Fate Therapeutics
FATE
Mkt Cap249.23M
Regenxbio
RGNX
Mkt Cap475.29M
About
IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), bronchiolitis obliterans syndrome post-lung transplant (BOS), and sarcoidosis-associated pulmonary hypertension (SAPH). A Phase 2a study in PH patients has been completed; a Phase 2 clinical study in BOS patients is ongoing; a Phase 2b clinical study in PH-ILD is ongoing; and a Phase 2 clinical study in SAPH is ongoing.
Show More
CEO
Brigette Roberts
Employees
38
Country
United States
ISIN
US22053A3059
Listings
0 Comments
Share your thoughts
FAQs
What is IRulya Therapeutics stock price today?▼
The current price of IRLA is $33.55 USD — it has increased by +1.82% in the past 24 hours. Watch IRulya Therapeutics stock price performance more closely on the chart.
What is IRulya Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange IRulya Therapeutics stocks are traded under the ticker IRLA.
What is IRulya Therapeutics market cap?▼
Today IRulya Therapeutics has the market capitalization of 34.12M
When is the next IRulya Therapeutics earnings date?▼
IRulya Therapeutics is going to release the next earnings report on November 18, 2026.
What were IRulya Therapeutics earnings last quarter?▼
IRLA earnings for the last quarter are -12.31 USD per share, whereas the estimation was -28.02 USD resulting in a +56.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IRulya Therapeutics revenue for the last year?▼
IRulya Therapeutics revenue for the last year amounts to 0 USD.
What is IRulya Therapeutics net income for the last year?▼
IRLA net income for the last year is -83.98M USD.
How many employees does IRulya Therapeutics have?▼
As of November 3, 2026, the company has 38 employees.
In which sector is IRulya Therapeutics located?▼
IRulya Therapeutics operates in the Health & Wellness sector.
When did IRulya Therapeutics complete a stock split?▼
The last stock split for IRulya Therapeutics was on June 30, 2026 with a ratio of 1:20.
Where is IRulya Therapeutics headquartered?▼
IRulya Therapeutics is headquartered in SOUTH SAN FRANCISCO, United States.